Riskpilot← Back to searchSign inGet full accessCH Fysioterapi AB
ABActiveOrg 5569248551Isafjordsgatan 39 B 5trPhysiotherapy activities · NACE 8695Est. 20130 employees
Revenue 2025
SEK 1,1M
+4% vs 2024
EBITDA margin
24.0%
+240% vs 2024
Equity ratio
90.1%
Financial strength
Net profit 2025
SEK 196K
+413% vs 2024
| Revenue | SEK 1,1M | +4% |
| EBITDA | SEK 275K | +240% |
| Net profit | SEK 196K | +413% |
| Total assets | SEK 613K | +35% |
| Equity | SEK 553K | +55% |
| Employees | 0 | — |
Legal name
CH Fysioterapi AB
Org number
5569248551
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
5 mars 2013
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva sjukgymnastik, akupunktur, friskvård, ortopedisk medicin inom Sverige och inom EU, handel med värdepapper, äga och förvalta fastigheter samt därmed förenlig verksamhet.
Address
Isafjordsgatan 39 B 5tr
Email
chrisafysio@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 022 | 1 092 | 1 516 | 1 104 | 1 149 |
| Staff expenses | — | −449 | −641 | −659 | −541 |
| EBITDA | 427 | 417 | 346 | 81 | 275 |
| Depreciation & amort. | −21 | −49 | −37 | −37 | −26 |
| EBIT | 406 | 367 | 309 | 44 | 250 |
| Net financials | −1 | −544 | −1 | 7 | 0 |
| Profit before tax | 528 | 159 | 308 | 51 | 250 |
| Tax | −125 | −33 | −77 | −13 | −54 |
| Net profit | 403 | 126 | 231 | 38 | 196 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 463 | 865 | 1 037 | 455 | 613 |
| Equity | 920 | 686 | 917 | 356 | 553 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 208 | 179 | 120 | 99 | 61 |
| Total debt | 208 | 179 | 120 | 99 | 61 |
EBITDA margin
24.0%
This company
15.8%
Market median
+52% vs market
20212025
Equity ratio
90.1%
This company
38.2%
Market median
+136% vs market
20212025
Return on equity
35.5%
This company
18.4%
Market median
+93% vs market
20212025
Net profit margin
17.1%
This company
8.1%
Market median
+111% vs market
20212025
Asset turnover
1.87×
This company
1.12×
Market median
+67% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CH Fysioterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Georgios Chatziioannidis | Deputy Board Member | 0 companies |
| Chrysanthi Hava | Board of Directors | 0 companies |